| Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 15 Oct 24 | CAMP4 Therapeutics | Common Stock | Conversion | Acquire C | No | No | 0 | 8,917 | 0.00 | 154,859 |
| 15 Oct 24 | CAMP4 Therapeutics | Series A Prime Preferred Stock Common Stock | Conversion | Dispose C | No | No | 0 | 100,014 | 0.00 | 0 |
| 16 Sep 24 | SYRS Syros Pharmaceuticals | Common Stock | Option exercise | Acquire M | No | No | 0 | 2,667 | 0.00 | 10,667 |
| 16 Sep 24 | SYRS Syros Pharmaceuticals | RSU Common Stock | Option exercise | Dispose M | No | No | 0 | 2,667 | 0.00 | 2,667 |
| 28 Jun 24 | SYRS Syros Pharmaceuticals | Common Stock | Sell | Dispose S | No | Yes | 5.12 | 34,837 | 178.37 k | 8,000 |
| 20 Jun 24 | OMGA Omega Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 2.2 | 25,000 | 55.00 k | 25,000 |
